Uncategorized
Non-Small Cell Lung Cancer (NSCLC) Drug Pipeline Analysis
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer types, making it the most common form of the disease. According to cancer.gov, in 2024, around 234,580 new cases of NSCLC are expected to be diagnosed in the United States alone, with 125,070 deaths predicted. Non-Small Cell Read more…